Updates and perspectives from our industry experts, scientists and product leaders.
Uncover the emerging role of AI in the revolutionary field of gene therapy and how it is paving the way for groundbreaking advancements.
Discover how Form Bio and Google Cloud’s Multiomics Suite will empower life scientists to accelerate research, development, and pre-clinical studies in personalized medicine and gene therapies.
Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.
We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.
Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.
Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.
Joe Nipko, PhD
July 11, 2023
Chris Haas
June 13, 2023
Nick Ketz, PhD
May 3, 2023
Andrew Busey & Kent Wakeford
March 27, 2023
Austin Day, PhD
March 2, 2023
February 10, 2023
September 20, 2023
The integration of AI and multiomics data insight generation is accelerating gene therapy development. Learn more.
Amicia Elliott
August 9, 2023
Discover how the fusion of wet lab data and AI is propelling life science and gene therapy research forward. Explore the cutting-edge advancements in this field and unlock new possibilities.
July 26, 2023
Despite having access to diverse data and a vast number of parameters, new DNA large language models often struggle to learn hard tasks. Our AI expert, Austin, shares his insights on the possible reasons why.
Jill Roughan, PhD
May 29, 2023
Discover the progression of AI from inception to present-day, and how it powers the efficient analysis of big data, revolutionizes gene therapy development, and advances biomanufacturing.
Claire Aldridge, PhD
May 15, 2023
Our Chief Strategy Officer, Claire Aldridge, PhD, explores the growing trend of early integration of biomanufacturing design to cut costs and time-to-market while improving patient access to gene therapy.
Sasha Maslova
April 18, 2023
Get insights from Sasha, our Artificial Intelligence (AI) Scientist, on a newly published article describing the potential undesirable effects of synonymous codon substitution and the role of computational methods to overcome these challenges.
DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.